Bandaram unit secures Rs 3.87 crore order for textbook materials

0 min read     Updated on 29 May 2026, 05:25 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

VSR Paper and Packaging Limited, a material subsidiary of Bandaram Pharma Packtech Limited, has secured a work order worth Rs.3,86,85,410 from M/s S. A. Printers for supplying raw materials for printing textbooks. The order is for the academic year 2026-27 with an execution period from June to August 2026. The disclosure confirms the order is from a domestic entity and is not a related party transaction.

powered bylight_fuzz_icon
41600320

*this image is generated using AI for illustrative purposes only.

VSR Paper and Packaging Limited, a material subsidiary of Bandaram Pharma Packtech , has secured a work order worth Rs.3,86,85,410 from M/s S. A. Printers for supplying raw materials for printing textbooks. The order involves the supply of paper, board, and other materials required for the academic year 2026-27. The execution period is scheduled from June to August 2026.

Order Details

The order was awarded by a domestic entity, M/s S. A. Printers, and is classified as a domestic work order. The disclosure confirms that the promoters, promoter group, or group companies hold no interest in the entity awarding the orders. Furthermore, the transactions do not fall under related party transactions.

Particulars Description
Name of Client M/s S. A. Printers
Nature of Order Work Order
Order Value Rs.3,86,85,410/-
Execution Period June-August 2026
Related Party Transaction Not Applicable

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Deepak Bandaram, Chairman and Managing Director, signed the disclosure on behalf of Bandaram Pharma Packtech Limited.

Historical Stock Returns for Bandaram Pharma Packtech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%-2.79%+0.32%-14.58%-22.47%+23.48%

How will this order impact VSR Paper and Packaging's revenue projections for the fiscal year 2026-27?

Does this contract signal a potential for recurring orders from M/s S. A. Printers in future academic years?

What are the margin expectations for supplying raw materials to the textbook printing sector compared to other segments?

Bandaram Pharma Packtech
View Company Insights
View All News
like16
dislike

Bandaram board to meet on May 30 to consider FY26 results

1 min read     Updated on 21 May 2026, 09:49 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Bandaram Pharma Packtech Limited will hold a board meeting on May 30, 2026, to consider the audited financial statements for the quarter and year ended March 31, 2026. The meeting will also review the standalone and consolidated audit reports.

powered bylight_fuzz_icon
40925946

*this image is generated using AI for illustrative purposes only.

Bandaram Pharma Packtech has announced that its board meeting will be held on Saturday, May 30, 2026. The meeting will take place at the company's registered office in Bangalore. The primary agenda for the meeting is to consider the audited financial results for the fiscal year ending March 31, 2026.

Agenda for the Meeting

The board will deliberate on several key financial documents. The meeting is convened pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Items for Consideration

  • Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended 31.03.2026.
  • Audit Report (Standalone and Consolidated) for the Quarter and Year ended 31.03.2026.
  • Any other business with the permission of the Chair.

The company has informed BSE Limited regarding the scheduling of this meeting. The intimation was submitted on May 21, 2026. The financial results and audit reports, once approved, will provide a comprehensive view of the company's performance for the full fiscal year.

Meeting Details

Detail Information
Date May 30, 2026
Day Saturday
Location Registered Office, Bangalore
Purpose Consideration of Audited Financial Statements for FY26

Historical Stock Returns for Bandaram Pharma Packtech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%-2.79%+0.32%-14.58%-22.47%+23.48%

How did Bandaram Pharma Packtech's revenue and profitability for FY26 compare to the previous fiscal year, and what growth trajectory can investors expect going forward?

Will the board consider announcing a dividend or any capital allocation changes alongside the FY26 audited results approval?

How has Bandaram Pharma Packtech's stock performance on BSE trended ahead of the results announcement, and what are analyst expectations for key financial metrics?

Bandaram Pharma Packtech
View Company Insights
View All News
like15
dislike

More News on Bandaram Pharma Packtech

1 Year Returns:-22.47%